Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines
Forecasted Federal grant Posted
- Opportunity number
- FOR-FD-25-010
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Applications expected due
- Not on record
- Award size
- $1,000,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Categories
-
- Agriculture
- Food and Nutrition
- Consumer Protection
- Eligible applicants
-
- Higher Education Inst. (Public)
- Higher Education Inst. (Private)
- Public or Indian Housing Auth.
- Non-501(c)(3) Nonprofits
- For Profit Organizations
- County Governments
- Unrestricted
- Small Businesses
- Tribal Organizations (Not Federally Recognized)
- Independent School Districts
- State Governments
- Tribal Governments (Federally Recognized)
- 501(c)(3) Nonprofits
- City/Township Governments
- Special District Governments
- Points of contact
-
- Terrin Brown terrin.brown@fda.hhs.gov (240) 402-7610
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Food and Drug Administration is forecasting a cooperative agreement to support dissemination of clinical practice guidelines, with an application due date not specified in this forecast. The program prioritizes guidelines whose development was previously supported by FDA cooperative agreements and requires applicants to propose a comprehensive plan to develop, evaluate, and distribute materials with a focus on equity.
Eligible applicants include higher education institutions (public and private), nonprofits (501(c)(3) and non-501(c)(3)), for-profit organizations, small businesses, state and local governments, tribal governments and organizations (federally recognized and not federally recognized), public or Indian housing authorities, independent school districts, and special district governments. The opportunity is unrestricted as to applicant type.
Award ceiling, award floor, expected number of awards, period of performance, place of performance, cost-sharing requirements, evaluation criteria, and weighting are not specified in this forecast posting.
The opportunity falls under CFDA 93.103, Food and Drug Administration Research. The FDA's broader research portfolio has obligated $4.17 billion across 3,008 grants, with cooperative agreements representing 58 percent of awards. Representative recent FDA cooperative agreements include the Reagan-Udall Foundation's five-year PRISM agreement ($1.3 million) and state laboratory flexible funding model agreements ranging from $250 thousand to $2.4 million.
Forecast synopsis
To support dissemination of clinical practice guidelines, particularly those whose development was previously supported by FDA cooperative agreements. Applicants must propose a comprehensive plan to develop, evaluate, and distribute materials to facilitate dissemination, with a focus on equity.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity